Introduction {#Sec1}
============

As seasonal breeders, the initiation of ovine reproduction is regulated by decreasing photoperiod, translated into a physiological signal by pineal neurohormone melatonin^[@CR1],[@CR2]^ Evidence suggests that melatonin acts upon both the ovine pituitary and hypothalamus, allowing modulation of the hypothalamic-pituitary-gonadal axis for seasonal reproduction^[@CR3]--[@CR5]^. Though the degree of reproductive regression varies amongst breeds, anoestrus tends to be more pronounced in the ewe, delineated by a halt in ovarian cycling^[@CR6],[@CR7]^. Whilst the ram retains some fertility in the non-breeding season, this period is characterized by a reduction in libido, testicular size, sperm quality and quantity, subsequently leading to a period of reduced productivity^[@CR8],[@CR9]^. Reproductive seasonality in the ram remains a hindrance in sheep production systems, as it limits reproductive potential, and thus the lifetime production of the animal.

Whether melatonin is able to influence ram fertility through additional mechanisms to photoperiodic translation remains to be elucidated. Melatonin receptors in the ram reproductive tract^[@CR10],[@CR11]^ and on spermatozoa^[@CR11]--[@CR13]^ indicate that melatonin likely has other direct roles in the onset and maintenance of seasonal fertility. *In vitro*, the binding of melatonin to receptors on Sertoli cells upregulates Sertoli-cell mediated Leydig cell testosterone production^[@CR10]^, and binding to melatonin receptors on spermatozoa appears to influence sperm capacitation and acrosome reactivity^[@CR14]^. Furthermore, increased seminal plasma concentrations of melatonin have been correlated to antioxidant enzyme glutathione reductase (GRD) activity^[@CR15]^. Melatonin itself is a potent antioxidant, able to scavenge a wide range of reactive oxygen species (ROS) that contribute to oxidative damage in sperm^[@CR16]^,which may partially explain its beneficial effects upon sperm quality *in vitro* across a range of species^[@CR17]--[@CR20]^.

Melatonin is currently utilised commercially to modulate ovine seasonality; in the form of a slow release implant, melatonin is demonstrated to advance the breeding season of the ewe^[@CR21]--[@CR27]^ Whilst exogenous melatonin is shown to increase ram testosterone secretion^[@CR28]--[@CR30]^ and testicular size^[@CR21],[@CR28],[@CR30],[@CR31]^, there are conflicting reports upon sperm production and quality^[@CR28],[@CR29],[@CR32],[@CR33]^ and discrepancies regarding when reproductive changes occur relative to melatonin implantation. Furthermore, it is unclear whether exogenous melatonin exerts a uniform effect across sheep breeds of varying seasonal reproductive regression, which may partially account for inconsistent results between studies.

In previous reports, it difficult to distinguish whether exogenous melatonin merely mimics the effect of decreasing photoperiod, consequently advancing the breeding season, or if there are further beneficial effects upon sperm production and function. Though melatonin-induced changes to sperm production and quality remain debated, hormone production is shown to distinctly vary with melatonin secretion in the ram^[@CR15],[@CR30],[@CR34],[@CR35]^. Endocrine markers such as testosterone, Anti-Mullerian Hormone (AMH) and inhibin are increasingly explored as indicators of testicular function. In other species, seminal plasma inhibin and AMH concentrations positively correlate with elevated spermatogenesis^[@CR36],[@CR37]^ reduced oxidative stress^[@CR36],[@CR38]^, and improved semen quality^[@CR39]--[@CR43]^. In the ram, changes in these endocrine profiles may be similarly correlated with sperm production and quality and could support that exogenous melatonin improves testicular function in the non-breeding season.

In Australia, despite the availability of melatonin implants to advance the breeding season of the ewe, there is no equivalent method to promote ram fertility in the non-breeding season. As past studies do not agree upon the effects of exogenous melatonin in the ram, both natural and artificial breeding remains restricted by the natural reduction in ram libido, semen production and quality in the non-breeding season. In the present study, we aimed to clarify the effects of exogenous melatonin upon ram reproductive parameters throughout the duration of the non-breeding season using two breeds of differing seasonal reproductive regression. To identify any long-term effects of melatonin upon ram reproduction, this study was continued into the breeding season subsequent to melatonin implantation.

Results {#Sec2}
=======

Melatonin alters ram behaviour and increases scrotal circumference {#Sec3}
------------------------------------------------------------------

In Poll Dorset rams, treatment with melatonin increased the likelihood of the ram producing an ejaculate during study weeks 9--12 (P = 0.007, see Supplementary Fig. [S1](#MOESM1){ref-type="media"}), though did not produce any effect in Merino rams.

There was no effect of treatment in either breed observed upon either weekly or advanced libido score (P \> 0.05, data not shown). Regardless of treatment, differences between the non-breeding and breeding seasons were observed in all rams during the advanced libido testing, with increases during the breeding season in the average number of ejaculations (0.73 ± 0.1 vs 2.266 ± 0.2, P \< 0.001), times the ram courted the ewe (18.466 ± 2.3 vs 33.14 ± 2.4 P \< 0.001) and number of attempted mounts (5.35 ± 1.1 vs 9.375 ± 1.3, P \< 0.001) during the 20 minute testing period.

Compared to their control counterparts, melatonin treated rams of both breeds recorded larger scrotal circumferences during study weeks 3--4, 6--10 (P \< 0.001, Fig. [1](#Fig1){ref-type="fig"}). In melatonin treated rams, scrotal circumference was greater than pre-implantation measurements from study week 3 onwards (P \< 0.001) whilst the scrotal circumference of control rams did not increase until the breeding season.Figure 1Scrotal circumference of melatonin implanted (-) and control (**-**) Merino and Poll Dorset rams (n = 31) from study week 0 (prior to implantation) to study week 30 (following breeding season). Weekly values are presented as means ± S.E.M. \*Indicates significant difference between treatment groups (P \< 0.05).

Ram weight varied (P \< 0.001) between control and melatonin treatment groups respectively only during study week 11 (90.00 ± 2.2 vs 88.07 ± 1.8 kg), 12 (92.25 ± 2.1 vs 90.07 ± 1.7 kg), 29 (91.00 ± 2.2 vs 95.50 ± 2.3 kg) and 30 (87.97 ± 2.1 vs 90.40 ± 2.1 kg).

There was no effect of treatment upon body condition score (P \> 0.05, see Supplementary Fig. [S2](#MOESM2){ref-type="media"}).

Ram sperm production, but not quality, is improved following melatonin implantation {#Sec4}
-----------------------------------------------------------------------------------

In both breeds, the sperm concentration of ejaculates collected from melatonin-treated rams was higher during week 9 compared to pre-implantation measures (4643.60 ± 56.44 vs 4331.09 ± 112 × 10^6^ spermatozoa/mL, respectively, p \< 0.05) and was lower during week 30 compared to pre-implantation (3885.15 ± 234.10 vs 4331.09 ± 112.12 × 10^6^ spermatozoa/mL, respectively; p \< 0.05). The sperm concentration of ejaculates collected from the control rams did not differ across the study period in comparison to study week 0 (P \> 0.05).

There was no effect of treatment or season upon ejaculate volume (P = 0.09), the overall average for which was 1.18 ml. However, both Merino and Poll Dorset melatonin -implanted rams increased the number of sperm per ejaculate compared to pre-implantation levels during study weeks 3--6 and 8--12 (P \< 0.05, Fig. [2](#Fig2){ref-type="fig"}). There was no effect of melatonin on the number of sperm per ejaculate in the following breeding season (P \> 0.05). Control rams did not differ from pre-implantation levels throughout the study period (P \> 0.05).Figure 2The difference in the number of spermatozoa × 10^6^ per ejaculate compared to week 0 measures for implanted and control**-**) Merino and Poll Dorset rams from study week 1 (1 week post-implantation) to study week 30 (following breeding season). Weekly values are presented as means ± S.E.M. Data is based off the 18 rams that collected from week 0 (Melatonin n = 9, Control n = 9). \*Indicates significant difference from week 0 within treatment group (P \< 0.05).

There was no effect of melatonin observed upon ejaculate consistency score in either breed (P \> 0.05, see Supplementary Fig. [S3](#MOESM3){ref-type="media"}).

There was no effect of melatonin treatment on ejaculate wave motion or subjectively scored sperm motility (P \> 0.05). Regardless of treatment group, all rams displayed higher wave motion scores during study weeks 9 and 29 (P \< 0.05, see Supplementary Fig. [S4](#MOESM4){ref-type="media"}). Compared to week 0, rams only displayed a greater percentage of sperm motility during week 9 (P \< 0.001, see Supplementary Fig. [S5](#MOESM5){ref-type="media"}), indicating a lack of seasonal distinction in sperm motility.

There was no effect of melatonin treatment or season on the percentage of total abnormal sperm (melatonin 6.60 ± 0.5%, control 11.19 ± 0.9%, P \> 0.05). Regardless of treatment or study week, Poll Dorset rams had a higher average percentage of abnormal sperm than Merino rams (14.6 ± 1.0% vs 4.3 ± 0.3% respectively, P = 0.024).

Differences in sperm DNA integrity between treatment groups were observed only in Poll Dorset rams, where control Poll Dorset rams showed higher average DNA fragmentation during study weeks 1--2,7--8 compared to melatonin-treated Poll Dorset rams (P \< 0.05, Fig. [3](#Fig3){ref-type="fig"}). There was no effect of melatonin upon sperm DNA integrity from Merino rams.Figure 3The percentage of sperm DNA fragmentation of melatonin implanted (-) and control (**-**) Poll Dorset rams (n = 8) from study week 0 (prior to implantation) to study week 30 (following breeding season). Weekly values are presented as means ± S.E.M. \*Indicates significant difference between treatment groups (P \< 0.05).

Melatonin modifies ram reproductive endocrinology {#Sec5}
-------------------------------------------------

Melatonin concentration in the seminal plasma of all melatonin- treated rams was higher (P \< 0.001) compared to control rams from study weeks 1--8 (Fig. [4](#Fig4){ref-type="fig"}). No difference between control and treatment was observed in the pre-implantation period, study weeks 9--12, nor in the following breeding season (P \> 0.05).Figure 4Seminal plasma concentrations of melatonin in implanted (-) and control (**-**) rams (n = 31) from study week 0 (prior to implantation) to study week 30 (following breeding season). Weekly values are presented as means ± S.E.M. \*Indicates significant difference between treatment groups (P \< 0.05).

Melatonin concentrations in blood plasma (Fig. [5](#Fig5){ref-type="fig"}) were higher in both breeds of melatonin-implanted rams at study week 6 compared to control rams (266.70 ± 0.5 pg/mL vs 4.28 ± 0.7 pg/mL respectively, P \< 0.001). There was no difference between melatonin and control rams during week 0 (8.96 ± 0.7 pg/mL vs 5.06 ± 1.4 pg/mL respectively, P \> 0.05), week 12 (29.60 ± 16.6 vs 2.87 ± 0.9 respectively, P \> 0.05) or week 30 (8.78 ± 0.8 vs 3.30 ± 0.7 respectively, P \> 0.05).Figure 5Blood plasma concentrations of testosterone in implanted (-) and control (**-**) rams (n = 31) at study week 0 (prior to implantation), 6, 12 and 30 (following breeding season). Weekly values are presented as means ± S.E.M. \*Indicates significant difference between treatment groups (P \< 0.05).

Prior to melatonin implantation (study week 0), no difference in serum testosterone concentrations was observed between treatment groups. All melatonin-treated rams had elevated testosterone concentrations at study week 6 and in the following breeding season at study week 30 in comparison to both controls and pre-implantation levels (P \< 0.005, Fig. [5](#Fig5){ref-type="fig"}). Control rams demonstrated no change in serum testosterone levels throughout the study (P \> 0.05).

There was no effect of treatment on concentration of AMH in seminal plasma throughout the study (P \> 0.05, see Supplementary Fig. [S6](#MOESM6){ref-type="media"}).

Regardless of study week or treatment, AMH concentration in seminal plasma was positively correlated with the number of sperm per ejaculate produced (*r* = 0.464, P \< 0.001) and sperm motility (*r* = 0.3242, P \< 0.001). The range of AMH concentration in ram seminal plasma was 1.55--325.30 ng/mL, with a median concentration of 91.14 ng/ml.

There was no effect of treatment on concentration of inhibin A in seminal plasma throughout the study (P \> 0.05, see Supplementary Fig. [S7](#MOESM7){ref-type="media"}). The concentration of inhibin A in seminal plasma was weakly correlated to the number of sperm per ejaculate (*r* = 0.1786, P = 0.0135). The range of inhibin A concentration in ram seminal plasma was 0.91--284.90 pg/mL, with median 35.78 pg/ml.

Discussion {#Sec6}
==========

The effects of exogenous melatonin upon ram reproduction have remained ambiguous for several years, and as such this study is the first to observe an extensive range of reproductive parameters over a long-term period following melatonin implantation in the ram. Individually, previous reports indicate that melatonin is able to influence some aspects of ram reproductive seasonality, though the time period over which these changes occur, and whether they occur simultaneously, is not well defined. We found that melatonin implantation results in a substantial increase in ram scrotal circumference, and importantly, sperm production with no compromise to semen quality. This study verifies the ability of exogenous melatonin to advance the ram breeding season and increase testicular function. Furthermore, as melatonin concentration and sperm production exceeded that of the natural breeding season, our results indicate that melatonin has other roles in improving testicular function aside from merely transcribing photoperiod to signal the onset of the breeding season. This study supports that melatonin merits application in industry to improve the reproductive efficiency of rams and allow for flexibility in reproductive management.

We observed that melatonin was elevated in ram seminal plasma the week following implantation, and that these levels remained higher in melatonin-treated rams until 10 weeks post implantation. Despite findings that seminal plasma melatonin concentration peaks 8--9 weeks after treatment in Raga Aragonesa rams^[@CR34]^ our highest concentrations were observed the week following implantation, supporting numerous reports of melatonin's ability to rapidly infiltrate peripheral tissues^[@CR44]^. Furthermore, we saw no difference between treatment groups from week 9 onwards, although reports suggest implants can release the hormone upwards of 12 weeks^[@CR34],[@CR45]^. Given that the same dosage of melatonin was applied across studies, these differences may be due to inter- breed variation. Though not statistically significant, we found similarly varying patterns of seminal plasma melatonin over time between Merino and Poll Dorset breeds (data not shown). As the Poll Dorset is a highly seasonal breed, and the Merino is not, differences in treatment response are somewhat expected, as British breeds tend to demonstrate a greater reproductive regression during the non-breeding period^[@CR46],[@CR47]^. Briefly, though melatonin-treated rams weighed slightly less during the final two study weeks of the non-breeding season, and were heavier during the following breeding season, this difference was very slight (within 3 kilograms of controls). Given that body condition score did not differ between treatment groups, this variation is likely biologically irrelevant to any effects of treatment.

Melatonin was substantially higher in ram blood plasma at 6 weeks post-implantation. These values occur in a similar timeframe and range to those previously reported in Mediterranean breeds^[@CR34]^. Interestingly, values of both seminal and blood plasma melatonin were comparable between the non-breeding and breeding season values in control rams, in agreement with previous findings using exogenous melatonin^[@CR34]^ but conflicting with reports of natural changes where seminal plasma melatonin was elevated in the breeding season^[@CR48],[@CR49]^. Given that we observed an increase in some reproductive parameters in the breeding period, it could be hypothesised that initial changes in melatonin concentration occur, and assert an effect, at the localised level of the hypothalamus and pituitary. Collection of data during daylight hours may have also impacted this result, as melatonin concentrations are known to be elevated during hours of darkness^[@CR50]^. As the regulation of ovine reproduction is thought to be primarily based upon the increasing pattern of melatonin exposure, rather than concentration, that precedes the shorter days of the breeding season^[@CR6],[@CR51]^, it is interesting that such high exogenous concentrations seem to be required to artificially exert a physiological effect in the ram. This suggests, given that sperm production in treated rams exceeded the natural breeding season values, that melatonin has other direct roles in testicular function, which we discuss further below.

In the ram, testosterone is primarily secreted from Leydig cells in the testes and is positively correlated with libido, sperm production and quality^[@CR10],[@CR52],[@CR53]^. Here, we found that plasma testosterone in melatonin-treated rams was elevated from baseline values at 6 weeks post-implantation, with levels decreased to that of control rams at 12 weeks post-implantation, coinciding with previous studies^[@CR34],[@CR54]^. This increase in testosterone supports that melatonin induces ram reproductive seasonality in both seasonal and non-seasonal breeds. Interestingly, our study showed that melatonin-treated rams had higher serum testosterone in the breeding season compared to both their control counterparts and baseline measures. As far as we are aware, this has not previously been reported. It is possible that this effect can be at least partially attributed to a direct influence of melatonin upon Sertoli cells. results which then binds to IGF-1 receptors upon Leydig cells to promote testosterone secretion. Furthermore, melatonin acts via melatonin-receptor 1 (MT1) to reduce oestradiol secretion, a known inhibitor of androgen production in the male gonad^[@CR10],[@CR55]^. In other tissue types, upregulation of melatonin receptors MT1 and MT3 is shown to occur following melatonin exposure^[@CR56],[@CR57]^. Though this study did not evaluate oestradiol concentrations in seminal plasma, relatively low seminal plasma oestradiol to testosterone ratios in melatonin-treated rams has previously been described^[@CR34]^. Oestradiol is normally present in the testes following conversion from testosterone by aromatase P450^[@CR58]^, where it then forms part of the negative feedback loop within the hypothalamic-pituitary-gonadal axis to regulate testosterone production^[@CR59]^. Melatonin is reported to inhibit aromatase activity through MT1 binding, subsequently decreasing the conversion of testosterone to estrogen^[@CR60]--[@CR63]^. Given that testosterone secretion from the testis appears to be directly influenced by MT1 binding^[@CR10],[@CR55],[@CR64]^, it is possible that exogenous melatonin in the ram upregulates the expression of melatonin receptors, which results in increased testosterone secretion, and reduces conversion of testosterone to oestrogen. Therefore, melatonin-treated rams may produce more testosterone in the subsequent breeding period compared to rams that have not been exposed to exogenous melatonin.

Another emerging marker of testicular function, AMH is produced by Sertoli cells, reaching a peak around puberty and retaining paracrine control of testicular function over the lifespan of the individual^[@CR39],[@CR40]^. As an identifying marker for Sertoli cell function, seminal plasma levels of AMH are correlated to improved semen production and quality in humans^[@CR39]--[@CR43]^, and to sperm concentration in the boar^[@CR65]^. Whilst increases in seminal plasma AMH in melatonin-treated rams failed to reach significance, this study supports that AMH is related to Sertoli cell function in the ram. We found a positive relationship between seminal plasma AMH and sperm production and sperm motility, despite one previous investigation in the ram suggesting that AMH in rete testis fluid has no correlation to Sertoli cell number^[@CR66]^. In the ram, increasing concentration of inhibin A are thought to mark the transition into breeding season, where peak concentrations indicate that testis are fully active and functional^[@CR67]^. Though seminal plasma Inhibin B is also similarly indicative of testicular function in other species^[@CR36],[@CR37],[@CR68]^, we found only a weak relationship between inhibin A in seminal plasma and sperm motility, and did not identify any other clear relationship to treatment or sperm parameters.

Findings concerning the effect of exogenous melatonin upon ovine sperm production and quality are widely varied. Some studies note improvements in testicular size^[@CR69]^, sperm motility^[@CR29],[@CR33],[@CR69]^ and concentration^[@CR69]^. On the contrary, these parameters have also exhibited no corresponding change to melatonin treatment^[@CR31],[@CR70]--[@CR72]^. This study aimed to clarify these discrepancies by utilising a relatively large sample size and biweekly measurements over a long-term period. In melatonin-implanted rams, we found increases in testicular size and sperm production, but no changes in sperm motility or morphology. Testicular size and the number of sperm per ejaculate were both elevated from 3 weeks post-implantation, suggesting a proliferation of testicular parenchyma as occurs in the natural breeding season. Past examinations of gonadotroph secretion patterns following melatonin treatment suggest that a down regulation of prolactin occurs, promoting an upregulation of follicle stimulating hormone (FSH) and luteinising hormone (LH)^[@CR3],[@CR35],[@CR73]^. Combined with elevated testosterone secretion following melatonin implantation, the upregulation of these endocrine factors likely contributes to the proliferation of functional cells and promotes spermatogenesis.

As an *in vitro* additive, melatonin is demonstrated to improve sperm quality across species^[@CR12],[@CR18],[@CR20],[@CR74]--[@CR76]^, where changes are primarily attributed to its antioxidant properties. Investigated to a far lesser extent, the effect of exogenous melatonin upon sperm quality in the ram remains debated^[@CR28],[@CR33],[@CR70],[@CR77]^. The present study demonstrated no effects of melatonin upon sperm motility or morphology throughout the entirety of the study, despite observing high levels of the hormone in the seminal plasma of melatonin-treated rams. Interestingly, there was little difference in sperm motility or morphology between the breeding and non-breeding seasons, suggesting these parameters may not be as greatly influenced by season in these breeds. We did observe differences in the percentage of sperm DNA fragmentation between melatonin and control Poll Dorset rams. Though melatonin and control Poll Dorset rams showed no difference at study week 0, control Poll Dorset rams had significantly higher levels of sperm DNA fragmentation during the several weeks of the non-breeding season compared to their melatonin-treated counterparts. However, as the melatonin group did not display any improvement following implantation, but rather retained consistently low fragmentation, we cannot conclusively credit these differences to treatment. This lack of improvement in overall sperm quality could be attributed to the fact that many rams in the melatonin group coincidentally had high quality ejaculates prior to implantation. However, melatonin did not negatively impact sperm quality despite causing increases in sperm production. As such, melatonin-treated rams were able to increase sperm output whilst maintaining ejaculate quality.

This study found that exogenous melatonin increased the likelihood of rams producing an ejaculate over time, with the effect only seen in the more seasonal Poll Dorset breed at 9--12 weeks post-implantation. Though there was an increase in reproductive behaviours during the breeding season, the lack of treatment effect upon all other measures of libido may be due to the housing of the rams, where all rams were maintained in a single flock throughout the study. Rams are known to vary their sexual behaviour in response to different social environments, and when in the presence of competitors, which may influence social hierarchy^[@CR78]--[@CR80]^. It is possible that both the housing and semen collection environment, where all rams were in direct competition, influenced the ram libido at time of collection and masked any influence of treatment. Testing during the 6--9 weeks post-implantation, where higher concentrations of melatonin and testosterone were present, may have yielded clearer results on the effect of melatonin upon ram sexual behaviour.

In summary, previous investigations into the effects of exogenous melatonin have presented conflicting information as to whether this pineal neurohormone is able to truly induce reproductive seasonality in the ram during the non-breeding period. This study has clarified these effects in both a seasonal and non-seasonal breed, supporting the ability of exogenous melatonin to advance the ram breeding season and improve sperm production. The findings of this study justify the use of melatonin in industry to increase ram reproductive potential, allowing for increased productivity and flexibility of reproductive management.

Methods {#Sec7}
=======

Animals {#Sec8}
-------

This study was carried out in strict accordance with the Australian Research Act 1985 No. 123 and the Australian code for the care and use of animals for scientific purposes 8^th^ edition (2013).

All experimental procedures were conducted with approval from the University of Sydney Animal Ethics Committee (approval 2017/1155). All animals were housed at the University of Sydney Sheep Research Unit, Cobbitty NSW, Australia. Poll Dorset (n = 14) and Merino (n = 17) rams were maintained as a single mob on pasture. Rams had access to improved pasture (couch, kikuyu, kangaroo grass, rye, broome, oat, triticale) and water ad libitum. Additional lucerne and lupins were supplemented up to three times a week.

Rams were selected for trial inclusion conditional to veterinary observation of normal reproductive parameters and health, with animals excluded from the study if testicular lesions, disease, low body condition score or high temperatures were observed. All animals were approximately 2 years old. Ram health was assessed by a veterinarian approximately every 6 weeks throughout the study, including assessment of blood biochemistry and hematology, respiratory and heart rate, body condition score, body temperature and visual observation of any external wounds or lesions (data not presented).

Teaser ewes (n = 20) involved in semen collection and libido testing procedures were housed as a single flock on improved pasture with access to water ad libitum. 4 ewes were synchronised for estrus approximately 2 weeks prior to each semen collection or libido testing event, using industry standard methods^[@CR81]^.

Experimental design {#Sec9}
-------------------

The study was conducted under VICH Good Clinical Practice (GCP) guidelines (International Co-operation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products, Good Clinical Practice (GL9), June 2000, effective July 2001.

The study was a 2 × 2 factorial experimental design, where rams were randomly allocated into melatonin and control groups, with an even distribution of weight and breed. With the exception of the primary investigator, all other investigators were blinded to treatment allocation to prevent bias in subjective measures. All rams were trained for semen collection 1 month prior to initiation of the study using teaser ewes and an artificial vagina. Following the initial two weeks of baseline data collection, where no animals had received melatonin, approximately half the rams in each breed (Merino + melatonin n = 8; Merino control n = 9; Poll Dorset + melatonin n = 7; Poll Dorset control n = 7) received three 18 mg subcutaneous melatonin implants (Regulin, Ceva Animal Health, Australia) behind their left ear. Control rams underwent the same implantation process with empty implanter guns.

Ram physical and behavioural data and duplicate semen samples were collected weekly over 14 weeks during the Australian non-breeding season (September-December) and 2 weeks in the following breeding season (April). During each week, two semen samples per ram were collected on the same day, approximately 3 hours apart. The study timeframe was based on evidence that implants release melatonin over an approximated 80 day period, with high serum and seminal plasma levels expected in the initial 8 weeks^[@CR34]^.

All equipment used was calibrated weekly prior to measurements. Unless otherwise stated all chemicals were supplied by Sigma-Aldrich (St Louis, MO, USA).

All subjective measurements were performed consistently by a trained individual throughout the study period.

Ram libido, scrotal circumference, body weight and condition score {#Sec10}
------------------------------------------------------------------

### Scrotal circumference {#Sec11}

Scrotal circumference was measured each week the day prior to semen collection by pushing the testes ventrally and placing livestock testes measuring tape at the widest anteroposterior diameter of the scrotum.

### Ram libido {#Sec12}

During weekly semen collection, ram libido was subjectively scored out of 4 (1: disinterested, no attempt to mount, 4: highly interested in ewe, mounting attempts, courting and flehmen displayed). Time taken to ejaculate also contributed to libido score. Scoring was performed by a single individual throughout the study. Whether a ram ejaculated or not was recorded for all semen collections.

Advanced libido testing was performed in at the end of the non- breeding season (study week 13) and in the following breeding season (study week 31). During testing, individual rams were placed in a pen with a single synchronized ewe and the number of ram behaviours (sniffs, flehmen response, courting, attempted mounting and ejaculations) performed were recorded over a 20 minute period. All rams were tested in the same testing environments and conditions. Libido testing pens were situated away from other sheep, with two observers per pen hidden from view. The test was replicated twice in both the breeding and non-breeding periods.

### Weight and body condition score {#Sec13}

At the same time and day each study week, rams were weighed in a calibrated walk-over weigh system (Gallagher Sheep Auto drafter, model G05714) following body condition scoring as per industry standard^[@CR82]^.

Semen production and quality {#Sec14}
----------------------------

### Semen collection {#Sec15}

Prior to study initiation, rams were trained to ejaculate into an artificial vagina in the presence of a synchronised teaser ewe. Using this method, two ejaculates were collected from each ram once per week throughout the duration of the study. Time taken to ejaculate was recorded, with no collection if the ram did not ejaculate within 4 minutes.

### Semen volume, concentration and consistency {#Sec16}

Immediately following collection, semen volume was observed by measuring the weight of the total ejaculate to the nearest 0.01 g. Concentration of the raw ejaculate was determined by averaging three readings on a calibrated colorimeter (Photometer SDM1, Minitube, Victoria Australia). Measurements of volume and concentration were then used to calculate the number of sperm per ejaculate.

Each ejaculate was subjectively scored for consistency (the ratio of sperm to seminal plasma) out of 5^[@CR81]^.

### Wave motion and motility {#Sec17}

Ejaculate wave motion was determined at 100× magnification as per industry protocol^[@CR81]^. Subjective motility was observed by diluting a portion of each ejaculate to a concentration of 100 × 10^6^ spermatozoa/mL with Salamon's diluent for fresh/chilled semen (300 mM Tris, 104 mM citric acid, 28 mM fructose, 15% v/v egg yolk, pH 7.3) and observing at 200× magnification.

### Sperm morphology {#Sec18}

Morphology slides for each ejaculate were prepared by diluting samples in phosphate-buffered saline shortly after ejaculation to a concentration of 100 × 10^6^ spermatozoa/ml.

The number of morphological abnormalities were subjectively determined per 200 cells for each ejaculate as per industry standard^[@CR81]^.

### Sperm DNA integrity {#Sec19}

Immediately after semen collection, 20 ul of each ejaculate was snap frozen by submerging in liquid nitrogen for 30 seconds and storing at −80 °C until assessment.

DNA integrity was assessed by flow cytometry (C6 BD Accuri, Becton Dickinson, New Jersey, USA) using acridine orange staining as similarly described by Evenson *et al*., 2000^[@CR83]^, with some adjustments. Briefly, samples were diluted to a concentration of 1--2 × 10^6^ spermatozoa/mL in 200 ul with 1× TNE buffer (0.15 M NaCl, 0.01 M Tris HCl, 1 mM disodium EDTA pH 7.4). Samples were then diluted with 400 ul acid detergent solution (0.08NHCl, 0.15 M NaCl, 0.1% Triton × 100 pH 1.2). Exactly 30 seconds later, samples were stained with 1.2 ml acridine orange (6 ug/ml). Stained samples were incubated for 3 minutes before assessment by flow cytometry, where green fluorescence (FL1) was detected using 533/30 band pass filter, and red fluorescence (FL3) a 670 long pass filter. Flow rate was set to 200 events per second, with a minimum of 5000 sperm cells recorded per sample.

DNA fragmentation was estimated by the relative amount of single stranded and double stranded DNA, indicated by the proportion of sperm demonstrating red fluorescence (i.e. red fluorescence/red + green fluorescence).

Seminal and blood plasma hormone analysis {#Sec20}
-----------------------------------------

### Seminal and blood plasma extraction {#Sec21}

Immediately after initial evaluation, the remainder of each ejaculate was centrifuged twice at 14,000 g for 20 minutes, with aspiration of the supernatant following each centrifugation in order to isolate seminal plasma and remove sperm cells. Seminal plasma was stored at −80 °C prior to analysis.

5--10 mL of peripheral blood was collected from the jugular vein of each ram during study weeks 0, 6, 12 and 30 the day prior to semen collection. To separate plasma from cells, samples were treated with heparin and centrifuged at 3500 × g for 20 mins. Plasma was stored at −80 °C prior to analysis.

### Melatonin {#Sec22}

Melatonin levels in seminal and blood plasma were determined by reverse-phase C-18 column extraction of plasma or seminal fluid samples, followed by double antibody radioimmunoassay (RKMEL-2, Buhlmann Laboratories AG, Schönenbuch, Switzerland) at the Adelaide Research Assay Facility. This assay is based on the Kennaway G280 anti-melatonin antibody^[@CR84]^ and uses ^\[125I\]^2-iodomelatonin as the radioligand.

250 µl aliquots of plasma or seminal fluid were extracted using reverse-phase C-18 columns and then resuspended in 1000 µl of supplied assay buffer, resulting in a 4-fold dilution. Control samples of plasma or seminal fluid were assayed at this dilution step, while samples from melatonin-treated rams were diluted a further 5-fold in assay buffer and assayed at a 20-fold dilution step. The extra dilution step is required to keep all samples within the standard curve range.

For the control and melatonin group samples, assay sensitivity was 2.0 pg/mL and 10 pg/mL respectively. Intra-assay CV was 6.6% and inter-assay CV was 12.1%.

### Testosterone {#Sec23}

Testosterone in blood plasma was quantified in duplicate using Mini-Vidas automated enzyme linked fluorescent assay (bioMérieux, NSW Australia) as per manufacturer's instructions. Assay sensitivity was 0.1 ng/ml. The Vidas system has been previously validated against established assays for detected of testosterone^[@CR85],[@CR86]^.

### Anti Mullerian hormone (AMH) {#Sec24}

Anti-Mullerian hormone concentrations were determined using Ovine AMH quantitative three-step sandwich ELISA kits (Ansh Labs LLC, Webster, TX) following manufacturer protocol. Briefly, 50 μL of calibrators, controls and seminal plasma samples were added in duplicate to AMH antibody coated microtiter wells. 50 ul AMH assay buffer premix was added to wells and incubated for 2 hours. Following initial incubation and washing, wells were incubated with 100 μl biotinylated AMH antibody for 1 hour. After this second incubation and washing, wells were incubated with 100 μL streptavidin-horseradish peroxidase conjugate for 30 mins. After the third incubation and washing, wells were incubated with 100 ml chromogenic substrate (TMB) for 9 minutes. Following the addition of stopping solution (sulfuric acid), and absorbance measured on a microtiter plate reader (TS800 microplate reader, Biotek) at 450 nm with background wavelength correction at 630 nm. Assay sensitivity was 0.025 ng/ml and intra and inter-assay variability was 9.93% and 4.95% respectively.

As only 18 of the 31 rams (Merino + melatonin n = 5; Merino control n = 5; Poll Dorset + melatonin n = 4; Poll Dorset control n = 4) produced ejaculates in the study weeks prior to implantation, only seminal plasma samples from this subset of rams was analysed in order to accurately compare later study weeks to the pre-implantation period.

### Inhibin A {#Sec25}

Inhibin-A concentrations in seminal plasma were determined using Inhibin A quantitative three-step sandwich ELISA kits (Ansh Labs LLC, Webster, TX) following manufacturer protocol. Briefly, 50 μl of calibrators, controls and seminal plasma samples were added in duplicate to Inhibin A antibody coated microtiter wells. 50 ul Inhibin A assay buffer premix was added to wells and incubated for 2.5 hours. Following initial incubation and washing, wells were incubated with 100 μl biotinylated inhibin α-subunit antibody for 1 hour. After this second incubation and washing, wells were incubated with 100 μl streptavidin-horseradish peroxidase conjugate for 30 mins. After the third incubation and washing, wells were incubated with 100 μl chromogenic substrate (TMB) for 12 minutes. Following the addition of stopping solution (sulfuric acid) and absorbance measured on a microtiter plate reader (TS800 microplate reader, Biotek) at 450 nm with background wavelength correction at 630 nm. Assay sensitivity was 2.3 pg/ml and intra and inter-assay variability was 7.8% and 11.32% respectively.

As with AMH analysis (2.4.4), only the subset of 18 rams collecting during pre-implantation weeks were analysed for seminal plasma inhibin A concentration.

Statistical analysis {#Sec26}
--------------------

The number of sperm per ejaculate, motility, DNA integrity and hormone concentrations were statistically analysed using linear mixed model regression (REML) in R 3.4.1^[@CR87],[@CR88]^. For the layout of these models, study week and breed were set as fixed effects and ram and ejaculate were set as random effects. Normality and homogeneity of residual variances were confirmed using the Shapiro-Wilk test and Bartlett's test, respectively. If required, the data were transformed to correct for unequal variances. Manipulation of the model to reduce heteroscedasticity of the residuals was performed if necessary and, in some cases, this required the application of a log transformation. If a log transformation was performed, the results were back transformed and presented as the geometric mean ± 95% confidence intervals.

All ordinal data (wave motion, ejaculate colour, libido) were analysed using ordinal logistic regression in R 3.4.1. using 'clmm' within the 'ordinal package'^[@CR89]^. Statistical significance was considered if P \< 0.05 and all values are reported as the mean ± standard error of the mean.

Data were compared between treatment groups on a per week basis, as well as within treatment group across the study period in order to determine any changes following melatonin implantation.

As only 18 of the 31 rams produced ejaculates in the study weeks prior to implantation, any statistical analysis comparing later study weeks to the pre-implantation period were based on this subset of rams (Merino + melatonin n = 5; Merino control n = 5; Poll Dorset + melatonin n = 4; Poll Dorset control n = 4). This was done to improve the accuracy of weekly comparisons, and in cases where within-week comparisons between treatment groups were not relevant. Data assessed using this method included sperm production and quality parameters, and AMH and Inhibin A concentrations in seminal plasma.

Correlations between AMH, Inhibin A and semen parameters were investigated by assessing associations using linear regression. If significant (P \< 0.05), Pearson's correlation test was then used to determine correlations. Correlations were considered significant if P \< 0.05.
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